Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Piper Sandler Sticks to Its Buy Rating for Argenx Se (ARGX)

Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?

GSK Gears Up for Q1 Earnings: Here's What to Expect

Viking (VKTX) to Report Q1 Earnings: What's in the Cards?

Maintaining the Edge: Argenx’s Hold Rating Amidst Rising Competition and Promising Therapy Results

Analysts’ Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)

Argenx Se (ARGX) Receives a Buy from Bank of America Securities

UBS Reaffirms Their Hold Rating on Argenx Se (ARGX)

Here’s Why argenx SE (ARGX) Pulled Back 23% in Q4

Buy Rating Affirmed for Argenx Se on Efgartigimod Progress and Regulatory Success

Wall Street Analysts Are Bullish on Top Healthcare Picks

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)

Buy Rating Affirmed for Argenx Se on Strong Pipeline and Market Potential

Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)

argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease

argenx Announces Annual General Meeting of Shareholders on May 7, 2024

Reaffirming Buy Rating for Argenx with New Price Objective Following Vyvgart’s Approval in Japan